JP2017509713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509713A5 JP2017509713A5 JP2017502571A JP2017502571A JP2017509713A5 JP 2017509713 A5 JP2017509713 A5 JP 2017509713A5 JP 2017502571 A JP2017502571 A JP 2017502571A JP 2017502571 A JP2017502571 A JP 2017502571A JP 2017509713 A5 JP2017509713 A5 JP 2017509713A5
- Authority
- JP
- Japan
- Prior art keywords
- aluminum
- adsorbed
- immunogen
- aluminum salt
- mpla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461969905P | 2014-03-25 | 2014-03-25 | |
| US61/969,905 | 2014-03-25 | ||
| PCT/US2014/045940 WO2015147899A1 (en) | 2014-03-25 | 2014-07-09 | Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509713A JP2017509713A (ja) | 2017-04-06 |
| JP2017509713A5 true JP2017509713A5 (https=) | 2017-08-17 |
Family
ID=51302762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017502571A Pending JP2017509713A (ja) | 2014-03-25 | 2014-07-09 | アルミニウム塩に吸着させたワクチンの免疫賦活能を強化するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170165358A1 (https=) |
| EP (1) | EP3122379A1 (https=) |
| JP (1) | JP2017509713A (https=) |
| KR (1) | KR20170016315A (https=) |
| CN (1) | CN106535929A (https=) |
| AU (1) | AU2014388299A1 (https=) |
| BR (1) | BR112016021692A2 (https=) |
| CA (1) | CA2943050A1 (https=) |
| MX (1) | MX2016012166A (https=) |
| RU (1) | RU2016141621A (https=) |
| SG (2) | SG10201808312YA (https=) |
| WO (1) | WO2015147899A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6918365B2 (ja) | 2015-08-19 | 2021-08-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 脂質化ｐｓａ組成物および方法 |
| EP3484441A4 (en) | 2016-07-15 | 2020-03-18 | President and Fellows of Harvard College | GLYCOLIPID COMPOSITIONS AND METHOD FOR USE |
| JP7385206B2 (ja) * | 2018-12-04 | 2023-11-22 | 国立大学法人大阪大学 | 免疫賦活剤 |
| CA3189004A1 (en) | 2020-07-22 | 2022-01-27 | 3H Bio. Co., Ltd. | A peptide used for immunotherapeutics |
| WO2022081707A1 (en) | 2020-10-13 | 2022-04-21 | The Government Of The United States, As Represented By The Secretary Of The Army | Sars-cov-2 dna vaccine and method of administering thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08506592A (ja) * | 1993-02-19 | 1996-07-16 | スミスクライン・ビーチャム・コーポレイション | ３−ｏ−脱アシル化モノホスホリル脂質Ａ含有のインフルエンザワクチン組成物 |
| WO1994019013A1 (en) * | 1993-02-19 | 1994-09-01 | Smithkline Beecham Corporation | Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a |
| ATE157882T1 (de) * | 1993-03-23 | 1997-09-15 | Smithkline Beecham Biolog | 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen |
| US20090214592A1 (en) * | 2005-02-16 | 2009-08-27 | O'hagan Derek | Adjuvant composition comprising aluminium phosphate and 3D-MPL |
| BRPI0811228A2 (pt) * | 2007-05-24 | 2014-10-21 | Glaxonsmithkline Biolog S A | Composição liofilizada, e, métodos para produzir uma composição liofilizada e para produzir uma composição imunológica. |
| SG184188A1 (en) * | 2010-03-26 | 2012-10-30 | Glaxosmithkline Biolog Sa | Hiv vaccine |
-
2014
- 2014-07-09 CN CN201480077507.5A patent/CN106535929A/zh active Pending
- 2014-07-09 RU RU2016141621A patent/RU2016141621A/ru not_active Application Discontinuation
- 2014-07-09 KR KR1020167025974A patent/KR20170016315A/ko not_active Withdrawn
- 2014-07-09 JP JP2017502571A patent/JP2017509713A/ja active Pending
- 2014-07-09 WO PCT/US2014/045940 patent/WO2015147899A1/en not_active Ceased
- 2014-07-09 CA CA2943050A patent/CA2943050A1/en not_active Abandoned
- 2014-07-09 MX MX2016012166A patent/MX2016012166A/es unknown
- 2014-07-09 AU AU2014388299A patent/AU2014388299A1/en not_active Abandoned
- 2014-07-09 BR BR112016021692A patent/BR112016021692A2/pt not_active Application Discontinuation
- 2014-07-09 EP EP14750386.6A patent/EP3122379A1/en not_active Withdrawn
- 2014-07-09 SG SG10201808312YA patent/SG10201808312YA/en unknown
- 2014-07-09 US US15/127,076 patent/US20170165358A1/en not_active Abandoned
- 2014-07-09 SG SG11201607404PA patent/SG11201607404PA/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shah et al. | Overview of vaccine adjuvants: introduction, history, and current status | |
| JP2017509713A5 (https=) | ||
| Atmar et al. | Adjuvants for pandemic influenza vaccines | |
| Kocourkova et al. | Vaccine ingredients: components that influence vaccine efficacy | |
| JP2018521028A5 (https=) | ||
| JP2011504486A5 (https=) | ||
| JP2014506916A5 (https=) | ||
| JP2009539965A5 (https=) | ||
| JP2011500662A5 (https=) | ||
| JP5712126B2 (ja) | 遅延型追加刺激免疫処置に対する迅速な応答 | |
| JP2008534467A5 (https=) | ||
| JP2015509522A5 (https=) | ||
| RU2005127200A (ru) | Менингококковые вакцины для введения через слизистую оболочку | |
| JP2021522296A5 (https=) | ||
| Stegmann et al. | Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation | |
| JP2015531389A5 (https=) | ||
| JP6564367B2 (ja) | 併用免疫原性組成物 | |
| NZ514961A (en) | Combination vaccines for protection against Streptococcus pneumoniae and RSV infection in children and the elderly | |
| JP2003526676A (ja) | ワクチン用のアジュバント | |
| JP2018172417A (ja) | 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法 | |
| RU2016141621A (ru) | Способы усиления эффективности иммуностимуляции адсорбированных на соли алюминия вакцин | |
| RU2017129340A (ru) | Композиции nеisseria мeningitidis и способы их получения | |
| JP2011506334A5 (https=) | ||
| WO2017122635A1 (ja) | 固定化ウイルス粒子を含むワクチン | |
| JP2015509963A5 (https=) |